Schedule 13D ownership disclosure
INDAPTUS THERAPEUTICS INC
Common Stock, Par Value $0.01 Per Share · CUSIP: 45339J105
Event date: 2025-12-22
- Filing-level shares
- 115,552.00
- Percent of class
- 5.4%
- Newman Michael JamesReported CIK 0001876315
Shares: 115,552.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-029593
- Form type
- SCHEDULE 13D/A
- Filer
- Indaptus Therapeutics, Inc.
- CIK
- CIK 1857044
- Filed
- Dec 30, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership